Deal Ticker: Kellerhals Carrard advised Arga Medtech SA on their recent oversubscribed financing round

Huge congratulations to Arga Medtech SA for their recent financing round.

Pulsed Field Ablation Innovator, Arga, just raised EUR 54 million in an oversubscribed financing round from, among other investors, Advent Life Sciences (UK), Earlybird Health (Germany), a new investor Gilde Healthcare (the Netherlands) as well as an undisclosed strategic investor. This start-up was founded by David Naele and Randy Werneth in 2020 to develop Coherent Sine-Burst Electroporation™ (CSE™), a next-generation cardiac ablation system for treating cardiac arrhythmias, including atrial fibrillation. This major financing round within less than 5 years after its incorporation shows the strong (to say the least) interest of the industry in Arga’s innovative CSE™ Pulsed Field Ablation system. It will also enable Arga to further develop its unique technology and expand operations.

Supporting Arga Medtech SA since its formation, Kellerhals Carrard advised on the swiss contractual aspects of this round and collaborated with Wilson Sonsini for the US side.

The Kellerhals Carrard team was led by Jean-Luc Chenaux (Partner, M&A), and further comprised Frédéric Rochat (Partner, M&A), François Kaiser (Partner, M&A), Serge Migy (Partner, Tax) Virginie Rodieux (Partner, IP) as well as Cindy Liu and Joséphine Marmy (Senior Associates, M&A) and Brian Jurt (Tax advisor).

We wish Arga all the best for the next milestones and look forward to assisting the team on the way!